other value-based care improvements

Abstracts
Clinical Benefits and Commonly Reported Adverse Events and Their Associated Costs in Patients With Chronic Lymphocytic Leukemia Treated With Bruton Tyrosine Kinase Inhibitors in First-Line and Relapsed/Refractory Settings
08/23/2024
Ibrutinib, acalabrutinib, and zanubrutinib are Bruton tyrosine kinase inhibitors (BTKis) approved for treatment of chronic lymphocytic leukemia (CLL). In this study, researchers used data from package inserts, clinical trials, and real-world...
Ibrutinib, acalabrutinib, and zanubrutinib are Bruton tyrosine kinase inhibitors (BTKis) approved for treatment of chronic lymphocytic leukemia (CLL). In this study, researchers used data from package inserts, clinical trials, and real-world...
Ibrutinib, acalabrutinib, and...
08/23/2024
Journal of Clinical Pathways
Abstracts
Building an Episode of Care to Reduce Time to Treatment
08/23/2024
When previously identifying causes of delay in cancer treatment, existing workflows often did not provide consistent timelines estimated for providers to diagnose and treat patients. To reduce time to treatment, researchers employed a pilot...
When previously identifying causes of delay in cancer treatment, existing workflows often did not provide consistent timelines estimated for providers to diagnose and treat patients. To reduce time to treatment, researchers employed a pilot...
When previously identifying...
08/23/2024
Journal of Clinical Pathways
Abstracts
Building an Episode of Care to Reduce Time to Treatment
08/23/2024
When previously identifying causes of delay in cancer treatment, existing workflows often did not provide consistent timelines estimated for providers to diagnose and treat patients. To reduce time to treatment, researchers employed a pilot...
When previously identifying causes of delay in cancer treatment, existing workflows often did not provide consistent timelines estimated for providers to diagnose and treat patients. To reduce time to treatment, researchers employed a pilot...
When previously identifying...
08/23/2024
Cancer Care Business Exchange

Upcoming Events

February 2 ⁠–⁠ February 5
LLM Winter Symposium
February 7 ⁠–⁠ February 9
Western AF Symposium
February 27 ⁠–⁠ March 1
DCLF
March 17 ⁠–⁠ March 19
GD Solid Tumors
March 22 ⁠–⁠ March 23
NP Institute
March 27 ⁠–⁠ March 30
TCIV
March 31 ⁠–⁠ April 2
Rx summit logo
April 21 ⁠–⁠ April 24
Symposium on Advanced Wound Care
April 30 ⁠–⁠ May 4
WoundCon
May 1 ⁠–⁠ May 3
See Full Calendar

Specialties

Events

Year Round Education

HMP Global Products

HMP Education Logo
HMP Omnimedia Logo
HMP Europe Logo
© 2025 HMP Global. All Rights Reserved.
Cookie Policy Privacy Policy Term of Use